Taylor Sundby, MD

National Cancer Institute
Bethesda, Maryland, United States

Presentation(s):

• Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM

  Thursday, November 17, 2022
  10:15 AM – 10:25 AM

• Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS

  Thursday, November 17, 2022
  1:40 PM – 1:48 PM